BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7533703)

  • 1. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group.
    Zanchetti A
    Drugs; 1994; 48 Suppl 1():23-30; discussion 30-1. PubMed ID: 7533703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
    Toal CB
    Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
    Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
    Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg.
    Toal CB;
    Clin Ther; 2001 Jan; 23(1):87-96. PubMed ID: 11219482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
    Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
    Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
    Isles CG; Kitchin NR
    J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intervention of long-acting nifedipine GITS reduces brachial-ankle pulse wave velocity and improves arterial stiffness in Chinese patients with mild hypertension: a 24-week, single-arm, open-label, prospective study.
    Zhang J; Wang Y; Hu H; Yang X; Tian Z; Liu D; Gu G; Zheng H; Xie R; Cui W
    Drug Des Devel Ther; 2016; 10():3399-3406. PubMed ID: 27799740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
    Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
    J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses.
    Hernández RH; Armas-Hernández MJ; Chourio JA; Armas-Padilla MC; López L; Alvarez M; Pacheco B
    Blood Press Monit; 2001 Feb; 6(1):47-57. PubMed ID: 11248761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension.
    Huang QF; Sheng CS; Li Y; Dou Y; Zheng MS; Zhu ZM; Wang JG;
    J Clin Hypertens (Greenwich); 2019 May; 21(5):648-657. PubMed ID: 30973207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group.
    Glasser SP; Ripa SR; Allenby KS; Schwartz LA; Commins BM; Jungerwirth S
    Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
    Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.